tripeptidyl peptidase i Tripeptidyl peptidase 1 acts as a peptidase - TPP1 disease elevated levels of TPP1 essentially prevent the accumulation of SCMAS Unraveling Tripeptidyl Peptidase I: Function, Genetics, and Disease Implications

TPP1 gene Tripeptidyl peptidase I (TPP1), also known as lysosomal pepstatin-insensitive protease, is a crucial enzyme within the human body. Encoded by the TPP1 gene, this peptidase plays a significant role in protein breakdown and is intricately linked to certain genetic disorders. Understanding the multifaceted nature of tripeptidyl peptidase I is essential for appreciating its biological significance and the consequences of its dysfunction.

The Enzymatic Role of Tripeptidyl Peptidase I

At its core, tripeptidyl peptidase I functions as a peptidase. This means its primary activity is to break down larger protein fragments, known as peptides, into their fundamental building blocks, amino acids. Specifically, TPP1 is a lysosomal serine protease characterized by its ability to cleave N-terminal tripeptides from substratesTPP1 tripeptidyl peptidase I CLN2 LPIC TPP-1. This process primarily occurs within the lysosomes, cellular structures that act as the cell's recycling and waste disposal system.The ELISA Kit is designed to detect native, not recombinant, TPP1. Appropriate sample types may include undiluted body fluids and/or tissue homogenates, ... The enzyme is synthesized as a 67 kDa proenzyme and is converted to its active 46 kDa form through non-enzymatic processes. While its main function involves exopeptidase activity, removing tripeptides sequentially from the N-termini of proteins and polypeptides, TPP1 also exhibits a weaker endopeptidase activityEntry - *607998 - TRIPEPTIDYL PEPTIDASE I; TPP1. This precise and controlled enzymatic action contributes to the overall protein homeostasis within cellsTripeptidyl-peptidase I (TPP1), also known as CLN2,is a lysosomal serine protease detected in alltissues examined, with highest levels shown in heart and .... The activity of tripeptidyl peptidase I can be measured in various biological samples, such as leukocytes and cultured fibroblasts, providing insights into its functional statusTripeptidyl peptidase I (TPP1) is defined asan enzyme encoded by the TPP1 gene, which is non-enzymically converted from a 67 kDa proenzyme to a 46 kDa active ....

The TPP1 Gene and Genetic Basis

The genetic blueprint for tripeptidyl peptidase I resides in the TPP1 gene. This gene encodes the enzyme, and mutations within it can lead to significant health consequences.This product is intended to beused as a blocking antigen for antibody competition assays. Any other use of this antigen is done at the risk of the user. The ... The TPP1 gene is a member of the sedolisin family of serine proteases. Understanding TPP1 gene transference and its mechanisms is crucial for comprehending the inheritance patterns of associated disordersDisease is characterized by seizures, ataxia, myoclonus, psychomotor retardation, vision loss and speech impairment..

Tripeptidyl Peptidase I in Health and Disease

Mutations in the tripeptidyl peptidase I (TPP1) gene are the underlying cause of a specific and severe neurological disorder known as Neuronal Ceroid Lipofuscinosis Type 2 (CLN2), also referred to as tripeptidyl peptidase-related neuronal ceroid lipofuscinosis.TPP1 -tripeptidyl peptidase1. Synonym(s): LPIC, TPP I, TPP-1, lysosomal pepstatin-insensitive carboxypeptidase. Previous symbol(s) and name(s): CLN2, SCAR7 ... This condition represents the classic late-infantile form of neuronal ceroid lipofuscinoses, making it one of the most common subtypes.作者：AA Golabek·2006·被引用次数：39—Mutations intripeptidyl-peptidase I(TPP I) underlie the classic late-infantile form of neuronal ceroid lipofuscinoses (CLN2), the most common ...

CLN2 disease is characterized by a progressive accumulation of storage material within cells, particularly the central nervous system作者：AA Gołabek·2006·被引用次数：2—Tripeptidyl-peptidase I (TPPI) is an acidic lysosomal peptidase thatremoves tripeptides from an unmodified N-terminus of small proteins and polypeptides.. This accumulation, often associated with specific protein components like SCMAS (storage compartment material, aggregation-prone protein), disrupts normal cellular function. Research indicates that elevated levels of TPP1 can essentially prevent the accumulation of SCMAS, highlighting the critical role of the enzyme in preventing disease pathology.

The symptoms of CLN2 disease typically manifest in early childhood and can include:

* Seizures

* Ataxia (loss of full control over bodily movements)

* Myoclonus (sudden, involuntary muscle jerks)

* Psychomotor retardation

* Vision loss

* Speech impairment

The severity and progression of these symptoms underscore the vital importance of functional tripeptidyl peptidase I for neurological health. Genetic testing for TPP1 gene mutations is a key diagnostic tool for TPP1-related neuronal ceroid lipofuscinosis.

Research and Applications

The study of tripeptidyl peptidase I extends beyond understanding genetic diseases. The enzyme and its related products are utilized in various research applications. For instance, Human Tripeptidyl-Peptidase I/TPP1 ELISA Kits, such as the one offered by RayBio, are employed to detect and quantify TPP1 levels in biological samples like serum, plasma, and cell culture supernatants. These kits are valuable tools for immunological research, cell biology studies, and protein-protein interaction analyses.Human Tripeptidyl-peptidase 1/TPP1 Protein Furthermore, recombinant tripeptidyl-peptidase I proteins can be used as a blocking antigen for antibody competition assays, aiding in the characterization and validation of antibodies targeting the enzyme.

In summary, tripeptidyl peptidase I (TPP1) is a vital lysosomal peptidase encoded by the TPP1 gene. Its role in protein catabolism is essential for cellular health, and its dysfunction, stemming from genetic mutations, leads to severe neurological conditions like CLN2 disease. Ongoing research into TPP1 and its associated pathways continues to illuminate its biological significance and potential therapeutic avenues.